Related Experiment Video
Updated: Oct 30, 2025

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis
1University of Connecticut School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, Farmington, CT, USA.
Insights
Hepatitis B (HBV) and Hepatitis C (HCV) cause significant global health issues like cirrhosis and cancer. While HBV vaccines are effective, HCV
Area of Science:
- * Hepatology and Virology: Focus on viral hepatitis pathogenesis and immunology.
- * Infectious Diseases: Addressing global health burdens of HBV and HCV.
- * Immunology: Examining host immune response to viral infections.
Background:
- * Hepatitis B virus (HBV) integrates into host DNA, complicating chronic infection eradication.
- * Hepatitis C virus (HCV) is an RNA virus with high mutation rates, leading to immune evasion and chronicity.
- * Both viruses are major causes of cirrhosis, hepatocellular carcinoma, and mortality worldwide.
Purpose of the Study:
- * To review the immunopathogenesis of HBV and HCV.
- * To explore viral properties enabling immune system evasion.
- * To discuss vaccine efficacy, limitations, and current/future treatment strategies.
Main Methods:
- * Comprehensive literature review of HBV and HCV immunopathogenesis.
- * Analysis of viral characteristics influencing host immune response.
- * Evaluation of vaccine development, efficacy, and treatment outcomes.
Main Results:
- * HBV vaccine development has reduced transmission, but chronic infection persists.
- * HCV's high mutation rate hinders vaccine development and contributes to treatment failures.
- * Direct-acting antivirals (DAAs) achieve high sustained virologic response rates (85-99%) but are not universally effective.
Conclusions:
- * Understanding viral immunopathogenesis is crucial for combating HBV and HCV.
- * Further therapeutic advancements are necessary to address treatment failures and achieve complete viral clearance.
- * Continued research into host-virus interactions is key for developing improved vaccines and treatments.
Abstract:
Despite the advances in therapy, hepatitis B virus (HBV) and hepatitis C virus (HCV) still represent a significant global health burden, both as major causes of cirrhosis, hepatocellular carcinoma, and death worldwide. HBV is capable of incorporating its covalently closed circular DNA into the host cell's hepatocyte genome, making it rather difficult to eradicate its chronic stage. Successful viral clearance depends on the complex interactions between the virus and host's innate and adaptive immune response. One encouraging fact on hepatitis B is the development and effective distribution of the HBV vaccine. This has significantly reduced the spread of this virus. HCV is a RNA virus with high mutagenic capacity, thus enabling it to evade the immune system and have a high rate of chronic progression. High levels of HCV heterogeneity and its mutagenic capacity have made it difficult to create an effective vaccine. The recent advent of direct acting antivirals has ushered in a new era in hepatitis C therapy. Sustained virologic response is achieved with DAAs in 85-99% of cases. However, this still leads to a large population of treatment failures, so further advances in therapy are still needed. This article reviews the immunopathogenesis of HBV and HCV, their properties contributing to host immune system avoidance, chronic disease progression, vaccine efficacy and limitations, as well as treatment options and common pitfalls of said therapy.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes
Mechanisms of Retrovirus-induced Cancers
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

